$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer

Cancer letters, v.210 no.2, 2004년, pp.189 - 196  

Yonemura, Yutaka (Peritoneal Dissemination Program, Shizuoka Cancer Center, 1007 Shimo-nagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan) ,  Endou, Yoshio (Department of Experimental Therapeutics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan) ,  Bando, Etsurou (Peritoneal Dissemination Program, Shizuoka Cancer Center, 1007 Shimo-nagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan) ,  Kuno, Kiyoshi (Peritoneal Dissemination Program, Shizuoka Cancer Center, 1007 Shimo-nagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan) ,  Kawamura, Taiichi (Peritoneal Dissemination Program, Shizuoka Cancer Center, 1007 Shimo-nagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan) ,  Kimura, Masashi (Peritoneal Dissemination Program, Shizuoka Cancer Center, 1007 Shimo-nagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan) ,  Shimada, Tsutomu (Department of Pharmacology, Kanazawa University Hospital, Kanazawa, Japan) ,  Miyamoto, Ken-ichi (Department of Pharmacology, Kanazawa University Hospital, Kanazawa, Japan) ,  Sasaki, Takuma (Department of Experimental Therapeutics, Cancer Research Institute) ,  Sugarbaker, Paul H.

Abstract AI-Helper 아이콘AI-Helper

AbstractThe effect of intraperitoneal (i.p.) administration of docetaxel was evaluated for preclinical evidence of anticancer activity in athymic mice bearing a gastric cancer cell line, MKN-45-P that shows a high rate of metastasis to the peritoneal cavity of nude mice. Nude mice were inoculated i....

주제어

참고문헌 (21)

  1. Cancer Chu 63 364 1989 10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V Peritoneal carcinomatosis in nongynecological malignancy. A prospective study of prognostic factors 

  2. J. Am. Med. Assoc. Cullinan 253 2061 1985 10.1001/jama.253.14.2061 A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs. fluorouracil and doxorubicin vs. fluorouracil, doxorubicin, and mitomycin 

  3. Ann. Intern. Med. MacDonald 93 533 1980 10.7326/0003-4819-93-4-533 5-Fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer 

  4. J. Clin. Oncol. Wils 9 827 1991 10.1200/JCO.1991.9.5.827 Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group 

  5. Cancer Ajani 68 1501 1991 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO;2-L Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy 

  6. Oncology Sugarbaker 58 96 2000 10.1159/000012086 Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure 

  7. Reg. Cancer Treat Sugarbaker 4 188 1993 Studies of the peritoneal-plasma barrier after systemic mitomycin C administration 

  8. Jacquet 53 1996 Peritoneal Carcinomatosis: Principles of Management Peritoneal-plasma barrier 

  9. Semin. Oncol. Markman 18 248 1991 Intraperitoneal chemotherapy 

  10. Biochemistry Diaz 32 2747 1993 10.1021/bi00062a003 Assembly of purified GDP-tubulin into microtubules induced by Taxol and Taxotere: reversibility, ligand stoichiometry and competition 

  11. Cancer Res. Debernardis 57 870 1997 p53 Status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel 

  12. Cancer Chemother. Parmacol. Marchettini 49 499 2002 10.1007/s00280-002-0439-1 Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model 

  13. Invest. New Drugs Dyke 13 1 1995 10.1007/BF02614214 Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere) 

  14. Gastric Cancer Yonemura 3 63 2002 10.1007/PL00011698 Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer 

  15. Eur. J. Cancer. Tanaka 32 226 1996 10.1016/0959-8049(95)00500-5 Evaluation of antitumor effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo 

  16. Natl Cancer Inst. Goel 81 1552 1989 10.1093/jnci/81.20.1552 Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin 

  17. Cancer Res. O'Dwyer 15 51 2041 1991 Phase I pharmacokinetic study of intraperitoneal etoposide 

  18. Jpn J. Cancer Chemother. Fushida 29 2164 2002 Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination 

  19. Jpn J. Cancer Chemother. Taguchi 21 1997 1994 Phase 1 clinical trial of RP 56976 (Docetaxel) a new anticancer drug 

  20. Clin. Cancer Res. van Tellingen 5 2918 1999 Rapid esterase-sensitive breakdown of polysorbete 80 and its impact on the lasma pharmacokinetics of docetaxel and metabolites in mice 

  21. J. Chromatogr. Biomed. Sci. Lee 724 357 1999 10.1016/S0378-4347(98)00566-0 Rapid and sensitive determination of paclitaxel concentration in mouse plasma by high-performance liquid chromatography 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로